{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,5,17]],"date-time":"2026-05-17T14:06:49Z","timestamp":1779026809796,"version":"3.51.4"},"reference-count":21,"publisher":"Wiley","issue":"2","license":[{"start":{"date-parts":[[2017,1,21]],"date-time":"2017-01-21T00:00:00Z","timestamp":1484956800000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by\/4.0\/"},{"start":{"date-parts":[[2017,1,21]],"date-time":"2017-01-21T00:00:00Z","timestamp":1484956800000},"content-version":"tdm","delay-in-days":0,"URL":"http:\/\/doi.wiley.com\/10.1002\/tdm_license_1.1"}],"funder":[{"DOI":"10.13039\/501100000325","name":"Wellbeing of Women","doi-asserted-by":"publisher","id":[{"id":"10.13039\/501100000325","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100000265","name":"Medical Research Council","doi-asserted-by":"publisher","award":["ELS203"],"award-info":[{"award-number":["ELS203"]}],"id":[{"id":"10.13039\/501100000265","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["onlinelibrary.wiley.com"],"crossmark-restriction":true},"short-container-title":["Cancer Medicine"],"published-print":{"date-parts":[[2017,2]]},"abstract":"<jats:title>Abstract<\/jats:title>\n                  <jats:p>\n                    Urocortin (\n                    <jats:styled-content style=\"fixed-case\">UCN<\/jats:styled-content>\n                    1) peptide shares structural and functional homology with corticotropin\u2010releasing factor (\n                    <jats:styled-content style=\"fixed-case\">CRF<\/jats:styled-content>\n                    ).\n                    <jats:styled-content style=\"fixed-case\">UCN<\/jats:styled-content>\n                    1 is significantly reduced in endometrial adenocarcinoma compared to healthy controls. However, there are no data which evaluate the effects of\n                    <jats:styled-content style=\"fixed-case\">UCN<\/jats:styled-content>\n                    1 in the endometrium, or how it is modulated. We used proliferation and transwell assays to determine the effect of\n                    <jats:styled-content style=\"fixed-case\">UCN<\/jats:styled-content>\n                    1 on the proliferation and migration of Ishikawa and\n                    <jats:styled-content style=\"fixed-case\">HEC<\/jats:styled-content>\n                    1A cells. We also determined the expression levels of\n                    <jats:styled-content style=\"fixed-case\">UCN<\/jats:styled-content>\n                    1 and its receptors produced by estrogen receptor agonists, and the effect of\n                    <jats:styled-content style=\"fixed-case\">UCN<\/jats:styled-content>\n                    1 on estrogen receptor expression, using quantitative polymerase chain reaction.\n                    <jats:styled-content style=\"fixed-case\">UCN<\/jats:styled-content>\n                    1 suppressed migration of endometrial cancer cells in vitro. This effect appears to be specific to\n                    <jats:styled-content style=\"fixed-case\">CRF<\/jats:styled-content>\n                    receptor 2 (\n                    <jats:styled-content style=\"fixed-case\">CRFR<\/jats:styled-content>\n                    2), as selective antagonism of\n                    <jats:styled-content style=\"fixed-case\">CRFR<\/jats:styled-content>\n                    2 but not\n                    <jats:styled-content style=\"fixed-case\">CRFR<\/jats:styled-content>\n                    1 completely eliminated suppression of migration. Activation of\n                    <jats:styled-content style=\"fixed-case\">ERA<\/jats:styled-content>\n                    reduced\n                    <jats:styled-content style=\"fixed-case\">UCN<\/jats:styled-content>\n                    1 expression, but only had a small effect on the expression of\n                    <jats:styled-content style=\"fixed-case\">CRFR<\/jats:styled-content>\n                    1. However, expression of\n                    <jats:styled-content style=\"fixed-case\">CRFR<\/jats:styled-content>\n                    2 was more notably reduced at both the m\n                    <jats:styled-content style=\"fixed-case\">RNA<\/jats:styled-content>\n                    and protein levels by activation of\n                    <jats:styled-content style=\"fixed-case\">ERB<\/jats:styled-content>\n                    .\n                    <jats:styled-content style=\"fixed-case\">UCN<\/jats:styled-content>\n                    1 in turn reduced both\n                    <jats:styled-content style=\"fixed-case\">ERA<\/jats:styled-content>\n                    and\n                    <jats:styled-content style=\"fixed-case\">ERB<\/jats:styled-content>\n                    expression, as assessed by real\u2010time quantitative\n                    <jats:styled-content style=\"fixed-case\">PCR<\/jats:styled-content>\n                    . We demonstrate that\n                    <jats:styled-content style=\"fixed-case\">UCN<\/jats:styled-content>\n                    1 significantly suppresses the migration of endometrial cancer cells but has no effect on their proliferation. Thus, loss of\n                    <jats:styled-content style=\"fixed-case\">UCN<\/jats:styled-content>\n                    1 in endometrial cancer may promote invasion and metastatic spread. There is a complex relationship between the\n                    <jats:styled-content style=\"fixed-case\">UCN<\/jats:styled-content>\n                    1 system and estrogen receptors, which may provide insights into endometrial carcinogenesis, a disease known to be driven by estrogen excess.\n                  <\/jats:p>","DOI":"10.1002\/cam4.967","type":"journal-article","created":{"date-parts":[[2017,1,21]],"date-time":"2017-01-21T00:10:07Z","timestamp":1484957407000},"page":"408-415","update-policy":"https:\/\/doi.org\/10.1002\/crossmark_policy","source":"Crossref","is-referenced-by-count":14,"title":["Urocortin suppresses endometrial cancer cell migration via CRFR2 and its system components are differentially modulated by estrogen"],"prefix":"10.1002","volume":"6","author":[{"given":"Gemma L.","family":"Owens","sequence":"first","affiliation":[{"name":"Division of Molecular &amp; Clinical Cancer Sciences School of Medical Sciences Faculty of Biology Medicine &amp; Health Manchester Cancer Research Centre University of Manchester  Wilmslow Road Manchester M20 4QL United Kingdom"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Kevin M.","family":"Lawrence","sequence":"additional","affiliation":[{"name":"Division of Molecular &amp; Clinical Cancer Sciences School of Medical Sciences Faculty of Biology Medicine &amp; Health Manchester Cancer Research Centre University of Manchester  Wilmslow Road Manchester M20 4QL United Kingdom"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Tom R.","family":"Jackson","sequence":"additional","affiliation":[{"name":"Division of Molecular &amp; Clinical Cancer Sciences School of Medical Sciences Faculty of Biology Medicine &amp; Health Manchester Cancer Research Centre University of Manchester  Wilmslow Road Manchester M20 4QL United Kingdom"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Emma J.","family":"Crosbie","sequence":"additional","affiliation":[{"name":"Division of Molecular &amp; Clinical Cancer Sciences School of Medical Sciences Faculty of Biology Medicine &amp; Health St Mary's Hospital University of Manchester  Oxford Road Manchester M13 9WL United Kingdom"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Berna S.","family":"Sayan","sequence":"additional","affiliation":[{"name":"Division of Molecular &amp; Clinical Cancer Sciences School of Medical Sciences Faculty of Biology Medicine &amp; Health Manchester Cancer Research Centre University of Manchester  Wilmslow Road Manchester M20 4QL United Kingdom"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Henry C.","family":"Kitchener","sequence":"additional","affiliation":[{"name":"Division of Molecular &amp; Clinical Cancer Sciences School of Medical Sciences Faculty of Biology Medicine &amp; Health St Mary's Hospital University of Manchester  Oxford Road Manchester M13 9WL United Kingdom"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Paul A.","family":"Townsend","sequence":"additional","affiliation":[{"name":"Division of Molecular &amp; Clinical Cancer Sciences School of Medical Sciences Faculty of Biology Medicine &amp; Health Manchester Cancer Research Centre University of Manchester  Wilmslow Road Manchester M20 4QL United Kingdom"}],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"311","published-online":{"date-parts":[[2017,1,21]]},"reference":[{"key":"e_1_2_6_2_1","doi-asserted-by":"publisher","DOI":"10.1016\/S0140-6736(15)00130-0"},{"key":"e_1_2_6_3_1","doi-asserted-by":"publisher","DOI":"10.1158\/1055-9965.EPI-04-0871"},{"key":"e_1_2_6_4_1","doi-asserted-by":"publisher","DOI":"10.1038\/378287a0"},{"key":"e_1_2_6_5_1","doi-asserted-by":"publisher","DOI":"10.1210\/endo.143.3.8694"},{"key":"e_1_2_6_6_1","first-page":"375","article-title":"Corticotropin\u2010releasing hormone receptor\u20101 in human endometrial cancer","volume":"15","author":"Graziani G.","year":"2006","journal-title":"Oncol. Rep."},{"key":"e_1_2_6_7_1","doi-asserted-by":"publisher","DOI":"10.1677\/joe.1.06726"},{"key":"e_1_2_6_8_1","doi-asserted-by":"publisher","DOI":"10.1677\/joe.0.173R009"},{"key":"e_1_2_6_9_1","doi-asserted-by":"publisher","DOI":"10.1210\/jc.80.1.185"},{"key":"e_1_2_6_10_1","doi-asserted-by":"publisher","DOI":"10.1111\/j.1749-6632.1999.tb08687.x"},{"key":"e_1_2_6_11_1","doi-asserted-by":"publisher","DOI":"10.1016\/j.peptides.2004.02.002"},{"key":"e_1_2_6_12_1","doi-asserted-by":"publisher","DOI":"10.1016\/j.cellsig.2014.02.002"},{"key":"e_1_2_6_13_1","doi-asserted-by":"publisher","DOI":"10.1016\/j.vph.2015.03.013"},{"key":"e_1_2_6_14_1","first-page":"3232","article-title":"Endogenous hormones as a major factor in human cancer","volume":"42","author":"Henderson B. E.","year":"1982","journal-title":"Cancer Res."},{"key":"e_1_2_6_15_1","doi-asserted-by":"publisher","DOI":"10.1038\/bjc.1988.44"},{"key":"e_1_2_6_16_1","doi-asserted-by":"publisher","DOI":"10.1016\/S0140-6736(05)66455-0"},{"key":"e_1_2_6_17_1","first-page":"1531","article-title":"Obesity, endogenous hormones, and endometrial cancer risk: a synthetic review","volume":"11","author":"Kaaks R.","year":"2002","journal-title":"Cancer Epidemiol. Biomarkers Prev."},{"key":"e_1_2_6_18_1","doi-asserted-by":"publisher","DOI":"10.1210\/jcem-67-3-460"},{"key":"e_1_2_6_19_1","doi-asserted-by":"publisher","DOI":"10.1159\/000127103"},{"key":"e_1_2_6_20_1","doi-asserted-by":"publisher","DOI":"10.1007\/BF02935643"},{"key":"e_1_2_6_21_1","doi-asserted-by":"publisher","DOI":"10.1530\/JOE-13-0228"},{"key":"e_1_2_6_22_1","doi-asserted-by":"publisher","DOI":"10.3892\/or.2013.2944"}],"container-title":["Cancer Medicine"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.wiley.com\/onlinelibrary\/tdm\/v1\/articles\/10.1002%2Fcam4.967","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/onlinelibrary.wiley.com\/doi\/pdf\/10.1002\/cam4.967","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/onlinelibrary.wiley.com\/doi\/full-xml\/10.1002\/cam4.967","content-type":"application\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/onlinelibrary.wiley.com\/doi\/pdf\/10.1002\/cam4.967","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,5,17]],"date-time":"2026-05-17T13:34:53Z","timestamp":1779024893000},"score":1,"resource":{"primary":{"URL":"https:\/\/onlinelibrary.wiley.com\/doi\/10.1002\/cam4.967"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2017,1,21]]},"references-count":21,"journal-issue":{"issue":"2","published-print":{"date-parts":[[2017,2]]}},"alternative-id":["10.1002\/cam4.967"],"URL":"https:\/\/doi.org\/10.1002\/cam4.967","archive":["Portico"],"relation":{},"ISSN":["2045-7634","2045-7634"],"issn-type":[{"value":"2045-7634","type":"print"},{"value":"2045-7634","type":"electronic"}],"subject":[],"published":{"date-parts":[[2017,1,21]]},"assertion":[{"value":"2016-05-23","order":0,"name":"received","label":"Received","group":{"name":"publication_history","label":"Publication History"}},{"value":"2016-09-23","order":2,"name":"accepted","label":"Accepted","group":{"name":"publication_history","label":"Publication History"}},{"value":"2017-01-21","order":3,"name":"published","label":"Published","group":{"name":"publication_history","label":"Publication History"}}]}}